Revelation Biosciences develops immunologic therapeutics and diagnostics designed to make the world a healthier place. Founded by Chester S. Zygmont and III in 2020, Revelation Biosciences is backed by investors that include National Securities Corporation and Global Health Funds and is headquartered in Menlo Park.